1.131I therapy effect on medium and large goiter with goiter with hyperthyroidism
Jiyuan HUANG ; Wenzhong SONG ; Qingjing DAI ; Zhenlin TANG ; Hongjun XIE ; Qunfang WEN
Clinical Medicine of China 2014;30(11):1144-1148
Objective To evaluate the effect of 131 iodine(131I) therapy in medium and large goiter with hyperthyroidism in order to investigate the influence of pretreatment with antithyroid drugs (ATD) methimazole(MMI) and propylthiouracide (PTU) on 131I therapy.Methods A total of 338 hyperthyroidism patients (136 cases for male,202 cases for female) with thyroid mass greater than 40 grams were treated with 131I in the People's Hospital of Sichuan Province.Thyroid function,thyroid 131I uptake ratio and thyroid imaging were measured before treatment were measured 1-3 months later after administration of 131I,and they were followed up for 6 months to 4 years.Results There were statistical difference between pretreatment and 3 months later of 131I therapy in terms of free triiodothyronine (FT3),(Free thyroxine) FT4.The level of FT3 decreased from (31.9 ± 16.2) pmol/L to (7.8 ±8.5) pmol/L(t =23.9,P =0.000) and level of FT4 decreased from (58.8 ± 22.2) pmol/L to (19.4 ± 16.9) pmol/L(t =25.4,P =0.000).Among 338 patients,109 patients (32.2%) were developed hypothyroidism,and 91 patients (26.9%) were cured,91patients (26.9%) with improved state,20 patients(5.9%) with ineffective and 27 patients(8.0%) with relapse after administration of 131I.The total effective rate was 94.1% (318/338).Thyroid weight,levels of FT3,FT4,thyroglobulin antibody(TGA),thyroid microsomal antibody(MCA) in effective group were (49.8 ± 9.97) g,(32.5 ± 16.3) pmol/L,(59.5 ± 22.2) pmol/L,(43.6 ± 35.3) %,(30.1 ± 22.6) % respectively,and were (56.9±15.7) g,(22.8 ± 12.8) pmol/L,(47.9 ±20.3) pmol/L,(22.8±30.0)%,(15.3 ±20.5)% respectively in ineffective group.There were statistically significant differences between the ineffective group and effective group (t =2.932,2.602,2.287,2.501,2.766 ; P =0.000,0.010,0.023,0.013,0.006).Logistic regression analysis was showed that weight of thyroid and serum FT3 were the most important factors in affecting 1131 therapy.Conclusion 131 I therapy for medium and large-sized goiter with hyperthyroidism is safe and effective.ATD may not reduce the effectiveness of subsequent 131I of hyperthyroidism.Thyroid weight and FT3 are the key influential factors in affecting 131I.
2.Performance of osteoporosis self-assessment screening tool for middle aged and elderly healthy Asians men in Chengdu
Jiyuan HUANG ; Wenzhong SONG ; Kejian SHI ; Xiayu FENG ; Mei HUANG ; Qunfang WEN
Chinese Journal of Geriatrics 2014;33(1):73-76
Objective To evaluate the screening effect of osteoporosis self-assessment tool for Asians (OSTA) in middle aged and elderly healthy men in Chengdu.Methods A total of 4042 healthy men aged 40 to 106 years received dual energy X-ray absorptiometry (DXA) assay,and OSTA index evaluation.Measurement sites included lumbar spine (L1-4),left femoral neck,trochanter,Ward's area,total hip and femoral shaft.All persons were classified into highosteoporosis-group (OSTA≤-4),mediumosteoporosis-group (-4 < OSTA≤≤-1),low osteoporosis-group (OSTA>-1),or the low risk-group (OSTA>-1) and high risk-group (OSTA≤-1) by OSTA scores.T-scores were compared between different measurement sites detected by DXA.The sensitivity,specificity,Kappa value and the area under receiver operating characteristic (ROC) curve (AUC) of OSTA in screening osteoporosis were evaluated.Results The prevalence of osteopenia and osteoporosis in lumbar spine,proximal femur were gradually increased along with aging.The detection rate of osteoporosis in lumbar spine and proximal femur were 16.2% and 24.0% respectively in subjects aged over 80 years.OSTA index in low-risk,medium-risk group,high-risk group were 85.0%,11.0%,4.0% respectively.The detection rate of osteoporosis in lumbar spine and proximal femur were 2.6% and 1.6% in low-risk group,10.4% and 10.4% in medium-risk group,and 29.3% and 30.5% in high-risk group,respectively.Taking OSTA ≤-1 as the cut-off value,the sensitivity and specificity of OSTA in screening osteoporosis in lumbar spine and femur by T-score<-1 were 28.1%,28.7 %,89.0% and 92.4% respectively,and by T-score≤-2.5 were 51.6%,63.2%,86.7% and 86.8% respectively.The consistency of diagnosis result between T-score and OSTA index according to the three versus two risk levels was 0.153 and 0.197 versus 0.195 and 0.243 Kappa value,respectively.The AUC of OSTA index for lumbar spine and femur by T-score<-1 and T-score≤-2.5 were 0.689 and 0.823,and for different age groups and different measurement sites were 0.639 and 0.899 (all P<0.001).Conclusions OSTA index has a certain ability in screening osteoporosis in men aged over 50 years.There are different screening results on osteoporosis among the different age groups.
3.Effects of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure in rats.
Chengyun, LIU ; Jingjing, WAN ; Qunfang, YANG ; Benling, QI ; Wen, PENG ; Xuelin, CHEN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2008;28(5):535-8
The effect of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure (SBP) of rats induced by warfarin was studied. Thirty healthy and adult rats were randomly divided into Warfarin group (n=10), Atorvastatin group (n=10) and normal control group (n=10). Caudal arterial pressure of rats was measured once a week, and 4 weeks later, aorta was obtained. Elastic fiber, collagen fiber and calcium accumulation in tunica media of cells were measured by Von Kossa staining. The results showed that warfarin treatment led to elevation of systolic blood pressure and aortic medial calcification. The chronic treatment also increased collagen, but decreased elastin in the aorta. However, the atorvastatin treatment had adverse effects. It was concluded that treatment with atorvastatin presented evidence of blood pressure lowing and calcification reducing. These data demonstrate that atorvastatin protected aortic media from warfarin-induced calcification and elevation of systolic blood pressure.
Aortic Diseases/chemically induced
;
Aortic Diseases/drug therapy
;
Aortic Diseases/*pathology
;
Blood Pressure/*drug effects
;
Calcinosis/chemically induced
;
Calcinosis/*drug therapy
;
Calcinosis/pathology
;
Heptanoic Acids/*pharmacology
;
Heptanoic Acids/therapeutic use
;
Hypertension/chemically induced
;
Hypertension/*drug therapy
;
Pyrroles/*pharmacology
;
Pyrroles/therapeutic use
;
Random Allocation
;
Rats, Wistar
;
Warfarin
4.Effects of Atorvastatin on Warfarin-induced Aortic Medial Calcification and Systolic Blood Pressure in Rats
LIU CHENGYUN ; WAN JINGJING ; YANG QUNFANG ; QI BENLING ; PENG WEN ; CHEN XUELIN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2008;28(5):535-538
Summary: The effect of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure (SBP) of rats induced by warfarin was studied. Thirty healthy and adult rats were randomly divided into Warfarin group (n=10), Atorvastatin group (n=10) and normal control group (n=10). Caudal arterial pressure of rats was measured once a week, and 4 weeks later, aorta was obtained. Elastic fiber, collagen fiber and calcium accumulation in tunica media of cells were measured by Von Kossa staining. The results showed that warfarin treatment led to elevation of systolic blood pressure and aortic medial calcification. The chronic treatment also increased collagen, but decreased elastin in the aorta. However, the atorvastatin treatment had adverse effects. It was concluded that treatment with atorvastatin presented evidence of blood pressure lowing and calcification reducing. These data demonstrate that atorvastatin protected aortic media from warfarin-induced calcification and elevation of systolic blood pressure.